652 related articles for article (PubMed ID: 28403874)
1. Intranasal immunization of pigs with porcine reproductive and respiratory syndrome virus-like particles plus 2', 3'-cGAMP VacciGrade™ adjuvant exacerbates viremia after virus challenge.
Van Noort A; Nelsen A; Pillatzki AE; Diel DG; Li F; Nelson E; Wang X
Virol J; 2017 Apr; 14(1):76. PubMed ID: 28403874
[TBL] [Abstract][Full Text] [Related]
2. A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.
Evenson D; Gerber PF; Xiao CT; Halbur PG; Wang C; Tian D; Ni YY; Meng XJ; Opriessnig T
Vaccine; 2016 Nov; 34(46):5546-5553. PubMed ID: 27742217
[TBL] [Abstract][Full Text] [Related]
3. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
[TBL] [Abstract][Full Text] [Related]
4. Immune responses of pigs immunized with a recombinant porcine reproductive and respiratory syndrome virus expressing porcine GM-CSF.
Li Z; Wang G; Wang Y; Zhang C; Huang B; Li Q; Li L; Xue B; Ding P; Cai X; Wang C; Zhou EM
Vet Immunol Immunopathol; 2015 Nov; 168(1-2):40-8. PubMed ID: 26300317
[TBL] [Abstract][Full Text] [Related]
5. Co-administration of saponin quil A and PRRSV-1 modified-live virus vaccine up-regulates gene expression of type I interferon-regulated gene, type I and II interferon, and inflammatory cytokines and reduces viremia in response to PRRSV-2 challenge.
Charerntantanakul W; Pongjaroenkit S
Vet Immunol Immunopathol; 2018 Nov; 205():24-34. PubMed ID: 30458999
[TBL] [Abstract][Full Text] [Related]
6. Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant.
Dwivedi V; Manickam C; Patterson R; Dodson K; Murtaugh M; Torrelles JB; Schlesinger LS; Renukaradhya GJ
Vaccine; 2011 May; 29(23):4058-66. PubMed ID: 21419162
[TBL] [Abstract][Full Text] [Related]
7. An interferon inducing porcine reproductive and respiratory syndrome virus vaccine candidate elicits protection against challenge with the heterologous virulent type 2 strain VR-2385 in pigs.
Fontanella E; Ma Z; Zhang Y; de Castro AM; Shen H; Halbur PG; Opriessnig T
Vaccine; 2017 Jan; 35(1):125-131. PubMed ID: 27876202
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Membrane-Bound Interleukin-15 as an Immunomodulatory Adjuvant Enhances NK and γδ T Cell Responses and Confers Heterologous Protection.
Cao QM; Ni YY; Cao D; Tian D; Yugo DM; Heffron CL; Overend C; Subramaniam S; Rogers AJ; Catanzaro N; LeRoith T; Roberts PC; Meng XJ
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643245
[TBL] [Abstract][Full Text] [Related]
9. A modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-1 vaccine protects late-term pregnancy gilts against heterologous PRRSV-1 but not PRRSV-2 challenge.
Jeong J; Kang I; Kim S; Park SJ; Park KH; Oh T; Yang S; Chae C
Transbound Emerg Dis; 2018 Oct; 65(5):1227-1234. PubMed ID: 29536637
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of routes of immunization of a live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in a heterologous virus challenge study.
Ouyang K; Hiremath J; Binjawadagi B; Shyu DL; Dhakal S; Arcos J; Schleappi R; Holman L; Roof M; Torrelles JB; Renukaradhya GJ
Vet Res; 2016 Mar; 47():45. PubMed ID: 26988085
[TBL] [Abstract][Full Text] [Related]
11. Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets.
Qiu HJ; Tian ZJ; Tong GZ; Zhou YJ; Ni JQ; Luo YZ; Cai XH
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):309-19. PubMed ID: 15963827
[TBL] [Abstract][Full Text] [Related]
12. Immune responses in mice vaccinated with virus-like particles composed of the GP5 and M proteins of porcine reproductive and respiratory syndrome virus.
Nam HM; Chae KS; Song YJ; Lee NH; Lee JB; Park SY; Song CS; Seo KH; Kang SM; Kim MC; Choi IS
Arch Virol; 2013 Jun; 158(6):1275-85. PubMed ID: 23392631
[TBL] [Abstract][Full Text] [Related]
13. Plasmid containing CpG oligodeoxynucleotides can augment the immune responses of pigs immunized with porcine reproductive and respiratory syndrome killed virus vaccine.
Quan Z; Qin ZG; Zhen W; Feng XZ; Hong J; Fei ZH
Vet Immunol Immunopathol; 2010 Aug; 136(3-4):257-64. PubMed ID: 20394988
[TBL] [Abstract][Full Text] [Related]
14. Inactivated porcine reproductive and respiratory syndrome virus vaccine adjuvanted with Montanide™ Gel 01 ST elicits virus-specific cross-protective inter-genotypic response in piglets.
Tabynov K; Sansyzbay A; Tulemissova Z; Tabynov K; Dhakal S; Samoltyrova A; Renukaradhya GJ; Mambetaliyev M
Vet Microbiol; 2016 Aug; 192():81-89. PubMed ID: 27527768
[TBL] [Abstract][Full Text] [Related]
15. Development of a porcine reproductive and respiratory syndrome virus-like-particle-based vaccine and evaluation of its immunogenicity in pigs.
Binjawadagi B; Lakshmanappa YS; Longchao Z; Dhakal S; Hiremath J; Ouyang K; Shyu DL; Arcos J; Pengcheng S; Gilbertie A; Zuckermann F; Torrelles JB; Jackwood D; Fang Y; Renukaradhya GJ
Arch Virol; 2016 Jun; 161(6):1579-89. PubMed ID: 27008569
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
[TBL] [Abstract][Full Text] [Related]
17. Immune responses induced by inactivated porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in neonatal pigs using different adjuvants.
Vreman S; Stockhofe-Zurwieden N; Popma-de Graaf DJ; Savelkoul HFJ; Barnier-Quer C; Collin N; Collins D; McDaid D; Moore AC; Rebel JMJ
Vet Immunol Immunopathol; 2021 Feb; 232():110170. PubMed ID: 33383553
[TBL] [Abstract][Full Text] [Related]
18. Positive inductive effect of swine interleukin-4 on immune responses elicited by modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine.
Peng J; Wang J; Wu J; Du Y; Li J; Guo Z; Yu J; Xu S; Zhang Y; Sun W; Cong X; Shi J
Viral Immunol; 2013 Dec; 26(6):404-14. PubMed ID: 24328935
[TBL] [Abstract][Full Text] [Related]
19. Immune response and protective efficacy of intramuscular and intradermal vaccination with porcine reproductive and respiratory syndrome virus 1 (PRRSV-1) modified live vaccine against highly pathogenic PRRSV-2 (HP-PRRSV-2) challenge, either alone or in combination with of PRRSV-1.
Madapong A; Saeng-Chuto K; Chaikhumwang P; Tantituvanont A; Saardrak K; Pedrazuela Sanz R; Miranda Alvarez J; Nilubol D
Vet Microbiol; 2020 May; 244():108655. PubMed ID: 32402335
[TBL] [Abstract][Full Text] [Related]
20. Vaccination against porcine reproductive and respiratory syndrome virus (PRRSV) reduces the magnitude and duration of viremia following challenge with a virulent heterologous field strain.
Calvert JG; Keith ML; Pearce DS; Lenz MC; King VL; Diamondidis YA; Ankenbauer RG; Martinon NC
Vet Microbiol; 2017 Jun; 205():80-83. PubMed ID: 28622868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
